Scarica l'app Stockscreener
7.7199
3.58%
-0.2401
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Fennec Pharmaceuticals Inc Borsa (FENC) Ultime notizie
(FENC) Price Dynamics and Execution-Aware Positioning - news.stocktradersdaily.com
Fennec Pharmaceuticals (TSX:FRX) Operate Today In Precision Oncology - Kalkine Media
(FRX) Equity Market Report (FRX:CA) - news.stocktradersdaily.com
Fennec Pharmaceuticals (TSE:FRX) Insider Sells C$1,799,524.00 in Stock - MarketBeat
Fennec's Pedmarqsi gets nod from U.K. regulators - MSN
Fennec Pharmaceuticals Announces Private Offering to Bolster Financial Position - MSN
(FRX) Risk-Controlled Trading Report (FRX:CA) - news.stocktradersdaily.com
Fennec Pharmaceuticals (TSE:FRX) Share Price Passes Below 50 Day Moving AverageWhat's Next? - MarketBeat
Fennec Pharmaceuticals Supports New Trial for Hearing Loss Prevention in Cancer Treatment - TipRanks
Analysts Offer Insights on Healthcare Companies: Fennec Pharmaceuticals (FENC) and Pfizer (PFE) - The Globe and Mail
How To Trade (FRX) (FRX:CA) - news.stocktradersdaily.com
Fennec Announces Trial Investigating Pedmark to Prevent Hearing Loss in Adult Men - marketscreener.com
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Tumors - marketscreener.com
Fennec Pharmaceuticals Announces Investigator-Sponsored Trial to Be Conducted by City of Hope in Metastatic Testicular Germ Cell Tumors - marketscreener.com
Fennec Pharma announces City of Hope PEDMARK trial in metastatic testicular tumors | FENC Stock News - Stock Titan
Trend Recap: Will Fennec Pharmaceuticals Inc stock benefit from automationQuarterly Investment Review & Free High Return Stock Watch Alerts - moha.gov.vn
Sentiment Recap: Is Fennec Pharmaceuticals Inc stock resilient to inflation2025 Sector Review & Reliable Intraday Trade Plans - moha.gov.vn
(FRX) Trading Performance and Risk Management (FRX:CA) - news.stocktradersdaily.com
Retail Surge: Will Fennec Pharmaceuticals Inc RV41 stock hit Wall Street targetsMarket Volume Report & Real-Time Sentiment Analysis - BỘ NỘI VỤ
Insider Sell: Rosty Raykov Sells 10,000 Shares of Fennec Pharmaceuticals Inc (FENC) - GuruFocus
Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $75,400 - Investing.com
Raykov Rosty sells Fennec Pharmaceuticals (FENC) shares for $75,400 By Investing.com - Investing.com Australia
Fennec Pharmaceuticals Director Sells 10,000 Shares - TradingView — Track All Markets
Dir Raykov Sells 10,000 ($75.4K) Of Fennec Pharmaceuticals Inc [FENC] - TradingView
Dir Raykov Files To Sell 10,000 Of Fennec Pharmaceuticals Inc [FENC] - TradingView — Track All Markets
What hedge fund moves indicate for Fennec Pharmaceuticals Inc. (RV41) stockQuarterly Portfolio Report & Safe Investment Capital Preservation Plans - Newser
Will Fennec Pharmaceuticals Inc. (RV41) stock hit Wall Street targetsTake Profit & Fast Entry High Yield Tips - Newser
Can Fennec Pharmaceuticals Inc. (RV41) stock withstand sector downturns2025 Trade Ideas & Expert Verified Stock Movement Alerts - Newser
How analysts revise price targets for Fennec Pharmaceuticals Inc. (RV41) stockJuly 2025 Breakouts & Safe Entry Point Identification - Newser
(FENC) as a Liquidity Pulse for Institutional Tactics - news.stocktradersdaily.com
Will Fennec Pharmaceuticals Inc. (RV41) stock benefit from Fed rate cutsDay Trade & Smart Allocation Stock Reports - Newser
Fennec Pharmaceuticals Reports Positive Results for PEDMARK® in Japan - MSN
Why Fennec Pharmaceuticals Inc. stock is popular among millennialsMarket Weekly Review & Daily Volume Surge Signals - Newser
(FRX) Technical Pivots with Risk Controls (FRX:CA) - news.stocktradersdaily.com
Is Fennec Pharmaceuticals Inc. stock resilient to inflationInflation Watch & Fast Entry Momentum Alerts - Newser
Fennec Pharmaceuticals (TSE:FRX) Stock Price Passes Below Fifty Day Moving AverageHere's What Happened - MarketBeat
Can Fennec Pharmaceuticals Inc. stock attract ESG capital inflows2025 Bull vs Bear & Technical Pattern Based Buy Signals - Newser
Fennec Pharmaceuticals : Statement of Changes in Beneficial Ownership (Form 4) - marketscreener.com
Stocks in play: Fennec Pharmaceuticals Inc. - The Globe and Mail
Fennec Pharmaceuticals Inc Announces Positive Results from PEDMARK® Trial in Japan - TradingView
Wedbush on Fennec Pharmaceuticals Latest Japan Trial Results - marketscreener.com
Pedmark Delivers In Japan Study — Less Hearing Loss, Same Cancer-Fighting Power - Benzinga
Fennec Pharmaceuticals announces positive topline results - marketscreener.com
Fennec Pharmaceuticals Inc. Announces Positive Topline Results from Investigator-Initiated Clinical Study of Pedmark®? in Japan to Reduce Cisplatin-Induced Hearing Loss - marketscreener.com
Fennec Pharmaceuticals Reports Positive Top-line Results From Japan Trial - marketscreener.com
Fennec Pharmaceuticals Says its Phase 2/3 Trial of Pedmark in Japan Meets Primary Endpoint - marketscreener.com
Fennec’s pediatric hearing protection drug shows positive results in Japan By Investing.com - Investing.com Australia
Fennec Pharmaceuticals Brief: Announcing "Positive" Topline Results From Investigator-Initiated Clinical Study of PEDMARK in Japan to Reduce Cisplatin-Induced Hearing Loss - marketscreener.com
Fennec Pharmaceuticals Announces Positive Topline Results From Investigator-Initiated Clinical Study of PEDMARK® in Japan to Reduce Cisplatin-Induced Hearing Loss - The Manila Times
Is Fennec Pharmaceuticals Inc. (RV41) stock a buy before new product rolloutQuarterly Trade Report & Daily Stock Trend Reports - Newser
(FRX) Long Term Investment Analysis (FRX:CA) - news.stocktradersdaily.com
Brokerages Set Adherex Technologies Inc. (NASDAQ:FENC) Price Target at $13.33 - Defense World
(FRX) Technical Data (FRX:CA) - news.stocktradersdaily.com
Fennec Pharmaceuticals to Participate in Piper Sandler 37th Annual Healthcare Conference - The Globe and Mail
0.42%
0.32%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):